Zasya provides Process Development Services those are designed to accelerate your journey from initial discovery to preclinical studies, focusing on delivering innovative, cost-effective, and high-quality solutions tailored to your needs.
Comprehensive route scouting to identify the most efficient and scalable synthetic pathways.
Screening of alternative reagents, catalysts, and solvents to optimize yield and sustainability.
Focus on reducing reaction steps and timelines for faster progression to preclinical stages.
Implementation of Design of Experiments (DoE) and Quality by Design (QbD) principles to identify critical parameters.
Development of robust methods tailored to meet the specific needs of your compound.
Demonstration batches in non-GMP kilo labs to mitigate risks during GMP-scale manufacturing
Early-stage feasibility assessments are conducted to evaluate the practicality and robustness of synthetic routes.
We address potential scale-up challenges, impurity profiles, and reaction safety considerations to de-risk your project.
Developing processes that can transition seamlessly from lab-scale (milligram to gram quantities) to larger scales required for preclinical testing.
Our scalable solutions ensure consistent quality and reproducibility across batches.
We employ cutting-edge analytical techniques, including NMR (1H, 13C, and 19F), LC-MS, HPLC, and GC, to monitor critical process parameters and ensure product integrity.
Our team develops fit-for-purpose analytical methods to support each phase of development.
Leveraging advanced methodologies like flow chemistry, photochemistry, and biocatalysis, we enhance efficiency and sustainability.
Our solutions are geared toward addressing complex synthetic challenges with innovative approaches.
Processes are designed to meet regulatory expectations, ensuring seamless documentation and compliance for later stages.
We lay a foundation for smooth technology transfer to GMP manufacturing facilities when required.
